In short. A lump after filler is not one condition. It may be product that has not settled, a collection in one place, the tissue’s inflammatory response, or an infection. Early lumps often soften over weeks; a lump that persists, grows, or becomes red, hot, or painful is assessed rather than watched. What was injected decides whether it can be dissolved.

Key points

  • Early unevenness is common and usually settles; a growing or painful lump is not.
  • Late lumps may be accumulated product, a nodule, or a biofilm.
  • Only enzyme-dissolvable fillers can be dissolved; others are managed over time.
  • Infection or biofilm is treated first; correcting appearance before control causes recurrence.
  • Fever, spreading redness, blistering, or dusky skin needs same-day care.

Is a lump after filler normal?

In the first weeks, a lumpy or uneven feel is common and expected. The filler has not yet integrated with the surrounding tissue, and swelling is not uniform. The area usually softens and smooths over the following weeks, which is why the result is judged at about two weeks and why a small irregularity found on the third day is not treated. A lump that is growing, or one that is red, hot, or painful, is not in that category.

What causes a late lump?

A lump appearing weeks or months after treatment may be a collection of product that has migrated or accumulated, a nodule formed by the tissue’s reaction to the material, or a biofilm — a low-grade bacterial colonisation that produces intermittent redness, swelling, and tenderness rather than an obvious infection. The history and examination distinguish them, and the treatment differs.

What was injected decides what can be done

A dissolvable gel filler can be broken down with an enzyme, and that is the only reliable reversal available. Calcium hydroxylapatite, poly-L-lactic acid, and polynucleotides cannot be dissolved, so a lump involving them is managed over time rather than reversed. Establishing the substance class comes before any plan.

Early lump Late lump Infection / biofilm
Timing First weeks Weeks to months Variable, may flare
Feel Uneven, settling Discrete or diffuse Tender, sometimes warm
Redness Usually none Sometimes Intermittent or spreading
First step Observe and review Establish material class Treat infection first
Reversal Usually settles Dissolve if dissolvable Control infection before correction

How are lumps treated?

Where the material is enzyme-dissolvable, dissolving is often the first approach, used in a measured way: dissolving too much at once removes the patient’s own tissue support as well as the filler and changes volume and skin quality, so correction is staged. Where the material is not dissolvable, options include observation, treatment directed at inflammation, and in some cases surgical removal of a discrete nodule. Where there is infection or a biofilm, treating that comes first, because correcting appearance before control produces recurrence.

What should I expect from treatment?

Improvement over weeks to months rather than resolution in one appointment. A nodule may reduce substantially and still be palpable. A biofilm may settle and then flare again, which is why follow-up continues. Every filler result remains temporary: the underlying material and the maintenance cycle continue.

When should I seek care rather than wait?

  • A lump is growing, or becomes red, hot, painful, or tender.
  • Fever, or redness and swelling spreading beyond the treated area — contact the treating team now; if unreachable, go to the nearest emergency department.
  • Skin over a lump blisters, breaks down, or turns white, grey, mottled, or dusky.

Sources

Internal links

Frequently asked questions

Is a lump after filler normal?

Early on, a lumpy feel is common because the filler has not integrated with the tissue, and it usually settles over the first weeks. A lump that persists beyond that, that grows, or that becomes red, painful or tender is assessed rather than watched.

Can lumps after filler be dissolved?

Only where the material was hyaluronic acid, which can be dissolved with an enzyme. Calcium hydroxylapatite, poly-L-lactic acid and polynucleotides cannot be dissolved, so a lump involving them is managed rather than reversed. That is why establishing what was injected matters first.

What if I do not know what was injected?

Say so. An unknown product changes the assessment: it affects what can be dissolved, how the tissue may have behaved, and how a new problem should be managed. Not knowing is common and is not a barrier to being treated, but it needs to be recorded rather than assumed.

Risks & Limitations

  • Vascular occlusion — filler blocking a blood vessel. This is a time-critical emergency that can cause skin loss and, rarely, vision loss.
  • Skin injury, blistering or a dusky patch over a treated area.
  • Nodules, lumps or delayed inflammatory reactions, which may need treatment or dissolving.
  • Infection at an injection site, including a deep collection that needs drainage.
  • Filler that has migrated away from the intended area.
  • Asymmetry or over-correction, which is harder to correct than under-correction.
  • An unknown product, which changes what can be done and how quickly.

When to Seek Care

  • Severe pain out of proportion to the injection, or skin turning white, grey, mottled or dusky — a vascular emergency; contact your treating team now, and if the team cannot be reached go to the nearest emergency department immediately.
  • Any change in vision — seek emergency care immediately.
  • Fever, spreading redness, warmth or pus at an injection site.
  • A hard, painful lump that is growing, or redness and swelling appearing weeks to months after treatment.
  • Skin breakdown or blistering over a treated area.

References & Further Reading

  • American Academy of Dermatology (AAD) — injectable safety information
  • American Society of Plastic Surgeons (ASPS) — dermal filler guidance
  • U.S. Food and Drug Administration (FDA) — approved dermal filler products
  • National Medical Products Administration (NMPA, China) — approved product status
  • Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.